CELLTRION

Mr. Seo served as the key organizer in Korea for the establishment of Celltrion, and joined the Company as Co-CEO at its inception in 2002. Mr. Seo supervises the administrative and financial operations of Celltrion in Korea, and oversees government relations, corporate financing and long-term corporate planning. He also serves as CEO of Nexol Corp. and Nexol Biotech Corp. Nexol is a successful business group based in Seoul active in biotechnology, software design, advertising and international trading.

Mr. Seo started his career at Samsung Electro-Mechanics Co. in 1983. After three years with Samsung, he joined the Korea Productivity Center, where his clients included some of the most successful companies during the early years of the Korean industrial revolution, including ByuckSan Corp., Samyang Co., Samsung Techwin, Kia Motors, Ssangyong Motors, and Anam Electronics. For eight years, from 1992 to 1999, he was a standing advisor (Executive Managing Director) to the Group Chairman of Daewoo, in charge of Daewoo Motors Co., while also serving as CEO of the Korea Quality Management Research Center, a Daewoo Group affiliate. In 2000, he incorporated Nexol Corp.

Mr. Seo received his B.S. in Industrial Engineering and M.S. in Business Management from KonKuk University in Seoul.

Don Gerson, Ph.D.: President (Technology & Manufacturing Divisional Group)

Dr. Donald Gerson is president (COO) of Technology & Manufacturing Divisional Group. He is totally responsible for Manufacturing, Quality Assurance, Quality Control , Engineering . Dr Gerson's 30 years of professional experience and knowledge makes a great contribution towards Celltrion's technology and manufacturing process development. As Managing Director of International AIDS Vaccine Initiative(IAVI), Dr.Gerson was responsible for manu- facturing clinical trial materials, process development, and planning for worldwide manufacturing of a vaccine against HIV. And as a vice president of manufacturing and development of Acambis, his resposibilities were the design, construction, start-up, licensing and implementation of new manufacturing facilities, processes and equipment. Especially under c GMP environment, Dr. Gerson is an authority in the field of setting and executing manufacturing quantities, schedules and policies for bulk and finished products, maintaining c GMP compliance and preparing for FDA inspections He earned a B.S., chemistry, University of Western Ontario in London, and further earned Ph.D. in biology, McGill University in Canada

Hyun-Soo Lee, Ph.D.: President (New Business Development Divisional Group)

Dr. Hyun-Soo Lee was named Senior Vice President of Celltrion in 2002 and is responsible for new business development of Celltrion, Inc..
Dr. Lee spent most of his professional career with Samyang Corp. and its affiliate companies, where for 35 years he served in various technical and managerial roles, eventually becoming Executive Vice President, Director and COO for the Biotech Division and Biotech R&D of Samyang Genex Corp. He was also a Director of the Korea Institute of Science and Technology Evaluation and Planning, and is a member of the Bio-Industry Strategy Committee of the Ministry of Commerce, Industry & Energy.

Dr. Lee oversaw the development and construction of the world's largest plant-cell-based biopharmaceutical manufacturing facility of 135,000 liters to produce Taxol. Dr. Lee has received many prestigious awards given to leading industrial scientists in Korea, including the Technology Award from the Korean Society for Applied Microbiology in 1998, the Jang Young Sil Award from the Ministry of Science and Technology in 1999, the Grand Prize of the Bio-Industry Award from the Ministry of Energy and Resources in 2000, and the Doyak Medal for the promotion of national science and technology in 2001.

Dr. Lee received his B.S. in Agricultural Chemistry, and Ph.D. in Food Science and Technology from Seoul National University.

Seung-il Shin, Ph.D.: Senior Advisor & Chairman of SAB, Celltrion, Inc.

Dr. Shin is a chairman of Celltrion’s Scientific Advisory Board (SAB) . He was the initiator and prime organizer in foundation of Celltrion, and currently oversees business development for Celltrion As VaxGen's Senior Advisor for International Development, Dr. Shin is also responsible for VaxGen's international program development to prepare VaxGen for worldwide distribution of its vaccines and other products.

Prior to joining VaxGen, he served with the United Nations, where he conceived, founded and directed an international initiative that ultimately led to the establishment of the International Vaccine Institute, now located in Seoul, Korea.

In 1984, Dr. Shin co-founded and served as the Chief Executive Officer of Eugene Tech International, where he led the company's effort to develop and market a hepatitis B vaccine that was eventually distributed widely in many developing countries. For two years, 1987-1989, he also served as Senior Executive Vice President and Director of the R&D Laboratories of Cheil Sugar & Co., in Seoul.

Before that, Dr. Shin was a Professor of Genetics at Albert Einstein College of Medicine in New York, and a founding member of the Basel Institute of Immunology in Basel, Switzerland.

Dr. Shin was educated in Korea and the United States in chemistry and biochemistry and in The Netherlands in genetics, and further trained in immunology in England. He earned a bachelor's degree in chemistry and a Ph.D. in biochemistry from Brandeis University.